Most Recommended Biotechnology Innovation Experts

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

In my role, I meticulously oversee various clinical projects, ensuring each phase is executed with precision and in compliance with GCP standards. Core Competencies: Clinical Trials Monitoring Clinical Safety Protocols Streamlined Clinical Operations Regulatory Compliance Mastery Educational Background: MSc in Molecular Science and Nanotechnology, Louisiana Tech University MSc in Medical Genetics, MGM University of Health Sciences With a robust educational foundation and a keen eye for detail, I have successfully navigated through different therapeutic areas and regions, delivering high-quality results consistently. My journey in the realm of clinical research is driven by an insatiable curiosity and a deep-seated commitment to advancing science and practice. Let’s Connect! If you are passionate about transforming health care and improving patient lives, or if you wish to exchange insights and collaborate on projects, feel free to connect with me. Together, let’s contribute to a healthier, more understanding world for individuals navigating through challenges.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

Andrea is an entrepreneur & global expert in 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲, 𝐠𝐫𝐞𝐞𝐧 𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐞𝐧𝐞𝐫𝐠𝐲 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧. He is the founder & "Chief Earth Officer" (i.e. a CEO on a mission for our planet) at 𝐢𝐥𝐥𝐮𝐦𝐢𝐧𝐞𝐦.𝐜𝐨𝐦, a leading sustainability information and data platform, and one of Angel List’s ‘𝐓𝐨𝐩 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐒𝐭𝐚𝐫𝐭𝐮𝐩 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞’. In 2024, illuminem achieved "the most participated round by key climate investors worldwide" and "the region's highest valuation for an early-stage climate company". Andrea is also the 𝐲𝐨𝐮𝐧𝐠𝐞𝐬𝐭 𝐩𝐫𝐨𝐟. 𝐚𝐭 𝐇𝐄𝐂 𝐏𝐚𝐫𝐢𝐬 (Europe's #1 business school), where he teaches Europe’s only Greentech course, with the goal of developing the next generation of sustainability leaders. Previous to illuminem, he served as the 𝐁𝐨𝐬𝐭𝐨𝐧 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 𝐆𝐫𝐨𝐮𝐩’𝐬 (𝐁𝐂𝐆) 𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐫𝐞𝐞𝐧 𝐂𝐡𝐚𝐦𝐩𝐢𝐨𝐧, leading projects on sustainable investments and innovation for multinationals & governments. Andrea has been recognized by the 𝐔𝐧𝐢𝐭𝐞𝐝 𝐍𝐚𝐭𝐢𝐨𝐧𝐬 as one of the 50 𝐆𝐥𝐨𝐛𝐚𝐥 '𝐈𝐦𝐩𝐚𝐜𝐭 𝐌𝐚𝐤𝐞𝐫𝐬' ("civil society leaders making the change we need to see"), and by Startup Italia as one of '𝐈𝐭𝐚𝐥𝐲’𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬'. He is the Sustainability & Innovation 𝐂𝐨𝐥𝐮𝐦𝐧𝐢𝐬𝐭 𝐟𝐨𝐫 𝐀𝐮𝐬𝐭𝐫𝐢𝐚’𝐬 𝐦𝐚𝐢𝐧 𝐧𝐞𝐰𝐬𝐩𝐚𝐩𝐞𝐫, Der Standard; a published author in the Journal of Financial Engineering; and a speaker at events hosted by COP, Davos, and universities around the world. His latest TEDx on ESG has become “the most-watched talk in Italian on sustainability.”

Misha Ghosh, Founder & CEO, IDiyas | Prolific Inventor & Strategic Innovation Leader Misha Ghosh is a globally recognized innovator and the Founder of IDiyas, a premier platform that democratizes patent analytics and inventor statistics. With a career spanning over two decades at the intersection of fintech and intellectual property, Misha has established himself as a preeminent authority on building institutional innovation engines. He writes a weekly newsletter that goes to over 50k inventors and patent attorneys worldwide. A prolific inventor, Misha holds 100 issued U.S. utility patents with more than 100 additional filings pending worldwide. His ability to translate complex technical concepts into commercial assets has earned him the highest accolades from the world’s leading financial institutions: Wells Fargo: Inducted into the Inventor Hall of Fame (2023). Mastercard: Awarded "Most Innovative Product" (2014). Bank of America: Named "Inventor of the Year" (2008). Today, through IDiyas, he leverages his deep expertise in "Patent Velocity" and alternative data to provide strategic insights to a global audience of inventors, investors, IP Attorneys, and Fortune 500 leaders.

Formerly a business owner in the fashion industry, I have redirected my career to catalyzing positive environmental change. As an Environmental Scientist and Project Manager I am hands on deploying ehnanced phytoremediation systems on contaminated and degraded sites throughout California. As an International Keynote Speaker, I am passionate about raising awareness and inspiring action on pressing environmental issues. Additionally, as a Native Plant Workshop Educator, I empower individuals to connect with their local ecosystems and promote biodiversity starting with their own backyard and communities. Join me in the environmental revolution, and together, we can make a lasting impact on our planet. Let's connect and collaborate for a greener, more sustainable future.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

James Bean is a pioneering cannabis industry expert and Founding CEO of Seeds Here Now, the longest continuously operating seed bank in the United States with 15 years of proven leadership. Since 2010, Bean has built an industry-leading catalog featuring 3,500+ strains from 80+ world-class breeders, establishing Seeds Here Now as the premier destination for authentic cannabis genetics. With a Plant Science degree from Oaksterdam University and 15 years specializing in cannabis genetics, Bean brings unparalleled expertise in breeder verification, genetic authenticity, and cultivation science. His knowledge spans feminized, regular, and autoflower seed production, pheno-hunting, breeding practices, and strain lineage documentation. Bean's industry authority is demonstrated through extensive media presence on major cannabis podcasts including The Adam Dunn Show (as "James Bean Man on the Scene"), The Dude Grows Show, The Pot Cast, and Grow Bud Yourself Podcast. He has personally vended at hundreds of cannabis trade shows including High Times Cannabis Cups and Canna Con events, and serves as a cannabis competition judge. As a heavy cannabis consumer with decades of personal experience, Bean possesses exceptional first-hand knowledge of strain effects and quality assessment. His business has served thousands of satisfied customers with germination guarantees and transparent practices, earning recognition including the 2023 Leafly Seed Bank Hall of Fame honor and Forbes media coverage. Bean actively supports cannabis community causes, mentors emerging businesses, and contributes educational content through articles and podcast appearances. His direct relationships with renowned breeders like TH Seeds, Exotic Genetics, La Plata Labs, Snow High Seeds, and Dominion Seed Company underscore his trusted position as the "#1 U.S. Broker of High Quality Cannabis Genetics." Based in Tulsa, Oklahoma, Bean continues to shape cannabis breeding trends, preserve rare genetics, and advance industry professionalism while maintaining Seeds Here Now's position as America's most trusted source for authentic cannabis seeds.

Shahadat Hussain, PhD, is a Research Associate in Division of Engineering at New York University in Abu Dhabi, UAE. Specializing in advanced materials science, he focuses on metamaterials, additive manufacturing (particularly laser powder bed fusion), triply periodic minimal surface (TPMS) lattices, and NiTi shape memory alloys for applications in aerospace, medical devices, and robotics. With a PhD in Materials Science and Technology, Shahadat combines computational design, experimental characterization, mechanical testing, and data science to tackle challenges like Ni evaporation, microstructural imperfections, and phase transformations in 3D-printed structures. His work advances tunable metamaterials with unique properties (e.g., negative refractive indices) and shape memory materials exhibiting superelasticity and recovery. Key publications include: 1. "Imperfections formation in thin layers of NiTi TPMS lattices" (Materials, 2022) 2. "Microstructural and surface analysis of NiTi TPMS lattice sections" (Journal of Manufacturing Processes, 2023) 3. "Phase Transformation Behavior of NiTi TPMS Lattices" (Journal of Materials Engineering and Performance, 2025) 4. Conference presentation at ASME IMECE 2022 on inhomogeneous microstructures Recent efforts feature bending analysis of single-phase metamaterial beams (communicated to Progress in Additive Manufacturing, 2026) and four-point flexural testing of interpenetrating phase composite metamaterials (2026). He collaborates with researchers, industry partners, and journals to push boundaries in rapid prototyping and innovative materials. Shahadat is passionate about sustainable technologies and multidisciplinary innovation. Visit his personal website for more details: www.shahadathussain.com. He maintains active profiles on LinkedIn, Google Scholar, ORCID, ResearchGate, and GitHub. Based in Abu Dhabi (PO Box 129188), he bridges theory and practical impact in cutting-edge engineering. Personal Website: www.shahadathussain.com

As Global Chief Innovation Officer at EY, I lead our AI, data, and emerging-tech initiatives across 400,000 people in 150+ countries, processing roughly a trillion lines of data annually for half of the Fortune 500. Our teams turn innovative ideas into business transformation across tax, assurance, consulting, and transactions. We are reinventing how EY delivers value to clients and society, always with responsible AI at the core of everything we do. Before joining EY, I led Accenture’s global Data & AI practice, guiding a 5,000+ strong team of data scientists and AI strategists to deliver enterprise AI solutions across industries. I then had the honor of serving as Emory’s Chief Data & AI Officer, where my focus on precision medicine was personal. We launched one of the first responsible AI governance programs in academic healthcare and deployed large language models (LLMs) that connected cutting-edge research to patient care. I have served on several boards focused on using technology to advance precision medicine and find a cure for childhood cancer, a mission that drives me every day. Along the way, I’ve been humbled to earn recognition including being named Technori’s #1 Innovation Leader to Watch in 2025, a Top 50 Global AI Leader by World Summit AI, and receiving Fast Company’s “World Changing Idea” award. But awards aren’t the goal. What motivates me is the opportunity to inspire teams and deliver innovations that help make the world a better place.

Ken is an independent peptide industry operator and educator based in Ho Chi Minh City, Vietnam. He is a contributor to PeptidesVietnam.com, a harm-reduction education resource covering GLP-1 peptides, research compounds, sourcing verification, and regulatory grey markets in Southeast Asia. With over ten years of biohacking experience, he has consulted for peptide brands scaling past $50k/month in monthly revenue and works directly with Vietnamese pharmacies, international hospitals, and regional suppliers. Ken writes and speaks on the grey-market realities of peptide access, quality control in research-grade supply chains, COA verification standards, and the specific regulatory landscape facing expats and biohackers in Vietnam and the broader SEA region. He is available to comment on weight loss peptide trends (semaglutide, tirzepatide, retatrutide), peptide legality and customs enforcement in Asia, health entrepreneurship in emerging markets, and biohacking culture among expats.

I'm a dedicated plant research scientist with a deep passion for harnessing the power of science and technology to enhance the field of agriculture. I am an expert in the development of Integrated Pest Management (IPM) strategies aimed at combating diseases in vegetable and fruit crops, both within the greenhouse and field environment, for improved productivity.I find great satisfaction in sharing my extensive agronomic knowledge and promoting agriculture products and services with different stakeholders.

I am Brian Tham, an Applied Artificial Intelligence undergraduate at Singapore Institute of Technology with a strong academic record and practical experience in AI research and development. My work focuses on advancing AI applications, particularly in the areas of model protection, computer vision, and machine learning. You may view my portfolio/website at https://tham.ai As a Research Student at Singapore Institute of Technology, I've contributed to significant work on AI model protection, specifically focusing on defending deep neural networks against model extraction attacks. My research encompasses model watermarking, adversarial robustness, and advanced defense mechanisms, with practical applications in medical imaging through UNet model implementation for brain MRI segmentation. My technical portfolio includes notable projects such as FoodVision, a real-time deep learning food detection system utilizing YOLOv8 technology, and a Speech Emotion Recognition system based on Wav2Vec2. I've also conducted comprehensive analyses of emerging technologies, including a detailed study of ransomware impacts across various industries and an evaluation of AI chatbot capabilities. Previously, I enhanced medical education at Lee Kong Chian School of Medicine, where my e-learning courseware development contributed to a 20% improvement in student test scores. My professional experience extends to the Ministry of Defence of Singapore, where I specialized in data processing automation and visualization using PowerBI and Excel. I hold multiple prestigious certifications, including Google Professional Machine Learning Engineer, Google Business Intelligence, and AI4I® – Proficiency in AI from AI Singapore. My technical expertise spans Python, machine learning frameworks (TensorFlow, PyTorch), and data analysis tools, complemented by a deep understanding of quantum computing, large language models, and autonomous vehicle technologies. This combination of academic excellence, practical research experience, and technical expertise positions me at the forefront of AI innovation and its real-world applications.